This site is intended for health professionals only
Wednesday 29 March 2017
Share |

Hazardous products

Hazardous products

Latest hazardous products news

04.08.16: Radiopharmaceutical precursor receives marketing authorisation
04.05.16: ‘Preventing occupational exposure to cytotoxic and other hazardous drugs’ launched...
25.09.15: Daratumumab is for treatment of European patients with heavily pre-treated multiple...
09.09.15: Daratumumab is for European patients with heavily pre-treated multiple myeloma
26.06.15: Adults with non-radiographic axial spondyloarthritis can be considered for once-...

Hazardous products analysis

Thursday 28 May 2015
An optimised production at the hospital pharmacies causes stockholding of the reconstituted chemotherapies, and hence...
Saturday 3 August 2013
In order to give compounded cytostatics longer shelf lives, better data are a prerequisite, and it would be opportune...
Tuesday 12 March 2013
It is important for healthcare professionals not only to understand the risks of intravenous neoplastic drugs, but also...
Tuesday 12 March 2013
Although the cumulative effect of exposure to several anticancer drugs over long periods is unclear, exposure should be...
Wednesday 25 July 2012
Oral cytotoxic drugs require the greatest need for careful consultation with the patient. The answer to the question:

You are leaving

You are currently leaving the Nursing in Practice site. Are you sure you want to proceed?


Respect for nurses: Sign up to our e-petition TODAY

The Nursing in Practice Respect campaign is now live! Over the coming months, we're set to highlight the vital contribution and efforts of primary care and community care nurses throughout the UK.

As part of our campaign, Nursing in Practice is looking to call on parliament to set up a debate to celebrate the vital work that you do.



Calling all primary care nurses! 'Like' our Nursing in Practice Facebook page to enter our free draw to win a £25 M&S voucher